Abstract
Introduction: Thalassemia minor is a prevalent genetic disorder around the world. A large number of mutations have been implicated in the development of a β-thalassemia minor phenotype. The diagnosis of β-thalassemia minor is made based on phenotypic parameters: microcytosis and elevated HbA2, with or without elevated HbF. We previously reported (ASH 2004, abstract #3761) that erythrocytic parameters of β-thalassemia minor are significantly different in patients with concomitant α-globin deletions, suggesting a reduction of ineffective erythropoiesis. The goal of the present study is to evaluate the effect of α and β-globin mutations on erythrocytic parameters in β-thalassemia minor patients.
Methods: Diagnosis of β-thalassemia minor was established using Hb HPLC analysis (Variant II, Bio-Rad) with increased HbA2 +/− increased HbF without expression of an abnormal Hb in cases of microcytosis. The DNA of consecutive cases with newly diagnosed β-thalassemia minor was extracted from leucocytes. A m-PCR was used to detect the presence of 7 α-globin gene deletions (-α3.7, -α4.2, --SEA, --FIL, --MED, --THAI, -α20.5). PCR and automated sequencing using fluorescence-based capillary electrophoresis (ABI PRISM 3100 Genetic Analyser) was performed to identify β-globin mutations causing the thalassemia phenotype. Data on age, sex and erythrocyte indices (Hb, MCV, RBC and RDW) was recorded. Student t-test was used to compare groups on the erythrocytic parameters.
Results: At the time of analysis, 175 samples were fully studied. At least one mutation in the β-globin gene was identified in 172 cases (98.3%, 95%IC: 95–99.5%). Groups were defined for comparison of erythrocytic parameters: mutations causing β+ phenotype, mutations causing β0 phenotype. Sub-groups were also analysed based on the presence or absence of α-globin gene deletions. Results are presented in Table 1 and 2.
Conclusion: The correlation between β-globin mutation and a β-thalasemia minor phenotype indicates that the phenotypic parameters correctly diagnoses β-thalasemia minor in the great majority of cases. Mutations classified as β0 affect more negatively the MCV, probably as a consequence of a reduced β-globin production and a greater level of ineffective erythropoiesis than in the β+ group. Higher MCV values in both β+ and β0 mutations when paired with an α-globin deletion compared with cases without an α-globin gene deletion could be explained by the concomitant reduction of functional α and β globin chain production, therefore causing less ineffective erythropoiesis.
Erythrocytic parameter . | β+ . | β° . | P . |
---|---|---|---|
Hb | 122.3 | 118.4 | NS |
RBC | 5.70 | 5.78 | NS |
MCV | 67.2 | 64.5 | <.001 |
RDW | 15.6 | 16.5 | <.001 |
%HbA2 | 5.26 | 5.55 | .022 |
%HbF | 1.15 | 1.75 | .020 |
Erythrocytic parameter . | β+ . | β° . | P . |
---|---|---|---|
Hb | 122.3 | 118.4 | NS |
RBC | 5.70 | 5.78 | NS |
MCV | 67.2 | 64.5 | <.001 |
RDW | 15.6 | 16.5 | <.001 |
%HbA2 | 5.26 | 5.55 | .022 |
%HbF | 1.15 | 1.75 | .020 |
Erythrocytic parameters . | β+αN . | β+ α deleted . | P . | β° αN . | β° α deleted . | P . |
---|---|---|---|---|---|---|
Hb | 121.2 | 129.5 | .057 | 117.9 | 124.4 | NS |
RBC | 5.69 | 5.78 | NS | 5.78 | 5.78 | NS |
MCV | 66.8 | 69.5 | .024 | 64.3 | 68.0 | .055 |
RDW | 15.7 | 15.2 | NS | 16.5 | 16.8 | NS |
%HbA2 | 5.3 | 5.3 | NS | 5.6 | 5.2 | NS |
%HbF | 1.2 | 0.9 | NS | 1.8 | 1.2 | NS |
Erythrocytic parameters . | β+αN . | β+ α deleted . | P . | β° αN . | β° α deleted . | P . |
---|---|---|---|---|---|---|
Hb | 121.2 | 129.5 | .057 | 117.9 | 124.4 | NS |
RBC | 5.69 | 5.78 | NS | 5.78 | 5.78 | NS |
MCV | 66.8 | 69.5 | .024 | 64.3 | 68.0 | .055 |
RDW | 15.7 | 15.2 | NS | 16.5 | 16.8 | NS |
%HbA2 | 5.3 | 5.3 | NS | 5.6 | 5.2 | NS |
%HbF | 1.2 | 0.9 | NS | 1.8 | 1.2 | NS |
Author notes
Corresponding author